TickerFactsScreenerDevelopers

Aclaris Therapeutics, Inc. (ACRS) — Operating Income

Annual figures by fiscal year, from SEC filings.

2013: -$5.26M2014: -$8.53M2015: -$20.67M2016: -$48.57M2017: -$54.36M2018: -$84.78M2019: -$111.06M2020: -$50.91M2021: -$89.72M2022: -$89.85M2023: -$97.36M2024: -$141.93M2025: -$76.38M-$76.38M
2013Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$76.38M+46.2%
2024-$141.93M-45.8%
2023-$97.36M-8.4%
2022-$89.85M-0.1%
2021-$89.72M-76.2%
2020-$50.91M+54.2%
2019-$111.06M-31.0%
2018-$84.78M-56.0%
2017-$54.36M-11.9%
2016-$48.57M-135.0%
2015-$20.67M-142.2%
2014-$8.53M-62.3%
2013-$5.26M—